1. The changing nature of aminoglycoside resistance mechanisms and prevalence of newly recognized resistance mechanisms in Turkey 
U. Över, D. Gür, S. Ünal, G.H. Miller 
Clinical Microbiology and Infection 
Volume 7, Issue 9, Pages (September 2001)
DOI: /j x x
Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

2. Figure 1
The sites of acetylation (AAC), adenylation (ANT) and phosphorylation (APH) of aminoglycoside molecules by modification enzymes and the genes encoding these enzymes. Inactivation sites of the clinically useful aminoglycosides (gentamicin (G), tobramycin (T), netilmicin (N), amikacin (A), isepamicin (I) or kanamycin (K)) are indicated for each enzyme.
Clinical Microbiology and Infection 2001 7, DOI: ( /j x x)
Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

3. Figure 2
The prevalence of aminoglycoside resistance mechanisms in Gram-negative bacteria.
Clinical Microbiology and Infection 2001 7, DOI: ( /j x x)
Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions